Skip to Content

← See all Sleep Aid brands

Sleep Aid by L.N.K. International, Inc.

Dosage form: tablet
Ingredients: DOXYLAMINE SUCCINATE 25mg
Labeler: L.N.K. International, Inc.
NDC Code: 50844-837

LNK 44-386

Active ingredient (in each tablet)

Doxylamine succinate 25 mg

Purpose

Nighttime sleep-aid

Use

helps to reduce difficulty in falling asleep

Warnings

Ask a doctor before use if you have
  • glaucoma
  • a breathing problem such as asthma, emphysema or chronic bronchitis
  • trouble urinating due to an enlarged prostate gland

Ask a doctor or pharmacist before use if you are

taking any other drugs.

When using this product
  • avoid alcoholic beverages
  • take only at bedtime 

Stop use and ask a doctor if

sleeplessness persists continuously for more than two weeks. Insomnia may be a symptom of a serious underlying medical illness.

If pregnant or breast-feeding,

 ask a health professional before use.

Keep out of reach of children.

 In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions
  • adults: take one tablet 30 minutes before going to bed; take once daily or as directed by a doctor
  • do not give to children under 12 years of age 

Other information
  • store at controlled room temperature 20º-25ºC (68º-77ºF)
  • see end flap for expiration date and lot number

Inactive ingredients

dicalcium phosphate, FD&C blue #1 aluminum lake, magnesium stearate, microcrystalline cellulose, sodium starch glycolate

Questions or comments?

Call 1-800-426-9391 8:30 AM-4:00 PM ET, Monday-Friday

Principal Display Panel- CVS

CVS 44-386


Principal Display Panel - Equaline

Equaline 44-386

Principal Display Panel - Equate

Equate 44-386

Principal Display Panel - Exchange Select

Exchange Select 44-386

Principal Display Panel - Freds

Freds 44-386

Principal Display Panel - HealthCare

HealthCare 44-386

Principal Display Panel - HEB

HEB 44-386

Principal Display Panel - Kirkland

Kirkland 44-386

Principal Display Panel - Leader

Leader 44-386

Principal Display Panel - Meijer

Meijer 44-386

Principal Display Panel - Health Mart

Health Mart 44-386

Principal Display Panel - Sunmark

Sunmark 44-386

Principal Display Panel - Rite Aid

Rite Aid 44-386

Principal Display Panel - Signature Care

Signature Care 44-386

SLEEP AID 
doxylamine succinate tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:50844-837
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOXYLAMINE SUCCINATE (DOXYLAMINE) DOXYLAMINE SUCCINATE25 mg
Inactive Ingredients
Ingredient NameStrength
ANHYDROUS DIBASIC CALCIUM PHOSPHATE 
FD&C BLUE NO. 1 
MAGNESIUM STEARATE 
CELLULOSE, MICROCRYSTALLINE 
Product Characteristics
ColorBLUEScore2 pieces
ShapeOVALSize10mm
FlavorImprint Code44;386
Contains    
Packaging
#Item CodePackage Description
1NDC:50844-837-223 BLISTER PACK in 1 CARTON
116 TABLET in 1 BLISTER PACK
2NDC:50844-837-272 BLISTER PACK in 1 CARTON
216 TABLET in 1 BLISTER PACK
3NDC:50844-837-191 BLISTER PACK in 1 CARTON
38 TABLET in 1 BLISTER PACK
4NDC:50844-837-712 BOTTLE in 1 CARTON
496 TABLET in 1 BOTTLE
5NDC:50844-837-461 BOTTLE in 1 CARTON
596 TABLET in 1 BOTTLE
6NDC:50844-837-8732 TABLET in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
APPROVED DRUG PRODUCT MANUFACTURED UNDER CONTRACTANDA04056404/11/2002
Labeler - L.N.K. International, Inc. (038154464)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.832867894MANUFACTURE(50844-837)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.967626305PACK(50844-837)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.832867837PACK(50844-837)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.038154464PACK(50844-837)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.868734088PACK(50844-837)

 
L.N.K. International, Inc.

← See all Sleep Aid brands

Medically reviewed on Jan 9, 2018

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide